By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Bristol Myers Squibb

Latest News

Earlier today

The V Foundation Announces New Category of V Scholar Grant for Black/African American… Business Wire (Press Release)11:52

In the last 7 days

FDA Approves Nivolumab in Combination with Chemotherapy for Advanced, Metastatic Gastric Cancer Pharmacy Times16:59 16-Apr-21

Latest Upgrades and Downgrades: Bristol-Myers Squibb, Splunk, Tesla TheStreet16:03 16-Apr-21

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy … Business Wire (Press Release)13:12 16-Apr-21

Bristol-Myers Squibb Settles MDRP Underpayment Claim For $75 Million JD Supra13:11 15-Apr-21

December 17th Options Now Available For Bristol Myers Squibb (BMY) Nasdaq11:24 15-Apr-21

European Commission approves Opdivo plus Cambometyx for advanced kidney cancer PMLiVE07:24 15-Apr-21

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cabometyx®… BioSpace19:13 14-Apr-21

Follow Warren Buffett Into These 3 Pharma Companies The Motley Fool07:21 14-Apr-21

Why This Bristol-Myers Squibb Stock Analyst Is Turning Bullish On The Pharma Company's Pipeline Yahoo! US15:30 13-Apr-21

Buy Bristol Myers, Analyst Says. It Isn't Getting Enough Credit for Its Drug Pipeline. Barron's Online10:05 13-Apr-21

Bristol Myers Squibb upgraded to buy from hold at Truist MarketWatch07:23 13-Apr-21

Liver Cancer Treatment Market Size Analysis, Competitive landscape and Insights for next 5 years Industry Today04:03 13-Apr-21

Evotec launches 'beLAB2122', translating academic innovation from leading German life science… DGAP01:33 13-Apr-21

AACR: BMS Checkpoint Inhibitor Flexes Muscle in Early-Stage Lung Cancer and Other Highlights BioSpace13:55 12-Apr-21

AACR: BeiGene details Novartis-partnered PD-1's first global pivotal win in lung cancer. Should … FiercePharma13:46 12-Apr-21

Bristol-Myers Squibb Company – Consensus Indicates Potential 21.8% Upside DirectorsTalk Interviews07:43 12-Apr-21

In the last month

Neoadjuvant Opdivo (nivolumab) Plus Chemotherapy Significantly Improves Pathologic Complete… Business Wire (Press Release)08:35 10-Apr-21

Bristol Myers Squibb’s Opdivo Combos Superior in Esophageal Cancer BioSpace08:11 9-Apr-21

Opdivo improves survival in oesophageal cancer PMLiVE07:51 9-Apr-21

Bristol Myers Squibb's regulatory missteps on Breyanzi can't all be blamed on COVID: analyst FiercePharma11:41 8-Apr-21

Bristol Myers Squibb Announces Opdivo (nivolumab) plus Chemotherapy and Opdivo plus Yervoy (ipilimumab) Demonstrate… BioSpace07:24 8-Apr-21

BMY vs. ILMN: Which Stock Should Value Investors Buy Now? Nasdaq12:29 7-Apr-21

Bristol's new myeloma CAR-T needs a hefty discount to be cost-effective, watchdogs say while… FiercePharma11:27 7-Apr-21

BMS, PsiOxus add an asset to Opdivo-oncolytic virus combo deal FierceBiotech10:28 7-Apr-21

The Zacks Analyst Blog Highlights: Google, Visa, PayPal, Bristol-Myers Squibb and Target Nasdaq08:44 7-Apr-21

PsiOxus Therapeutics Updates Agreement with Bristol Myers Squibb to Advance their Clinical… Business Wire (Press Release)03:05 7-Apr-21

Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know Nasdaq19:08 6-Apr-21

3 Reasons Warren Buffett Loves Bristol-Myers Squibb Seeking Alpha18:08 5-Apr-21

Bristol-Myers Squibb Company – Consensus Indicates Potential 19.8% Upside DirectorsTalk Interviews17:20 5-Apr-21

Ireland central to alleged $1.4bn ‘abusive’ tax shelter by pharma giant The Irish Times19:33 2-Apr-21

Bristol-Myers Squibb agrees to pay $75 million to settle allegations of underpaying Medicaid… STAT12:22 2-Apr-21

Funding the Next Generation of Cancer Therapies Genetic Engineering and Biotechnology News07:00 2-Apr-21

Bristol Myers Squibb Settles Medicaid Rebate Suit For $75M Law36019:11 1-Apr-21

IRS Investigating Bristol Myers Squibb Over Tax Scheme Worth $1.4 Billion BioSpace13:13 1-Apr-21

IRS alleges Bristol Myers dodged $1.38B in taxes with offshore patent scheme: report FiercePharma12:31 1-Apr-21

Bristol Myers' Abecma launch tools? Digital CAR-T platform and provider training, for two FiercePharma11:50 1-Apr-21

Bristol-Myers Squibb to Pay $75 Million to Resolve False Claims Act Allegations of Underpayment of Drug Rebates Owed… U.S. Department of Justice (Press Release)11:49 1-Apr-21

Bluebird: CAR T cell therapy approval puts us on the road to broader oncology success Biopharma Reporter10:56 1-Apr-21

Opdivo plus Cabometyx approved in the EU for advanced renal cancer PharmaTimes04:53 1-Apr-21

Bristol Myers Squibb's Zeposia and Biogen's Vumerity Place Competitive Pressure on Established… PR Newswire (Press Release)08:09 31-Mar-21

BMS’ Opdivo plus LAG-3 antibody relatlimab show promise in melanoma PharmaTimes06:44 31-Mar-21

Hospital Pharmaceuticals Market to Set New Growth Story | Pfizer, Johnson and Johnson,… Industry Today04:35 31-Mar-21

European Commission Approves Cabometyx® in Combination With Opdivo® as a First-Line Treatment… Business Wire (Press Release)01:07 31-Mar-21

SCOTUS Scuttles Forum Shopping Litigation Tourists JD Supra13:53 30-Mar-21

Bristol Myers Squibb to Host Virtual Investor Event to Discuss AAD VMX Highlights Business Wire (Press Release)06:59 30-Mar-21

Should You Buy Bristol Myers Squibb Stock At $63? Forbes06:31 30-Mar-21

FDA green light for BMS, bluebird bio’s CAR-T therapy Abecma in multiple myeloma PharmaTimes05:18 30-Mar-21

Another Roadside Attraction: The Supreme Court’s Latest Route Guidance on Personal Jurisdiction in Products Liability… JD Supra19:54 29-Mar-21

Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know Nasdaq18:51 29-Mar-21

Why bluebird bio Stock Jumped Today The Motley Fool15:56 29-Mar-21

Supreme Court Issues Landmark Personal Jurisdiction Decision JD Supra15:45 29-Mar-21

SCOTUS Extends Specific Jurisdiction to Ford in Products Cases JD Supra15:35 29-Mar-21

Bluebird, BMS win FDA nod for first BCMA-targeting CAR T therapy BioWorld14:01 29-Mar-21

Bristol Myers, bluebird bio have their BCMA CAR-T nod, but latecomer J&J could have an… FiercePharma12:32 29-Mar-21

After Many Delays, BMS and bluebird Win Approval for Multiple Myeloma CAR-T BioSpace09:37 29-Mar-21

Global Chronic Myeloid Leukemia (CML) Treatment Market to 2029 - Featuring Novartis,… Business Wire (Press Release)09:18 29-Mar-21

Bluebird Shares Jump as FDA Approves Cancer Therapy Barron's Online09:02 29-Mar-21

Here’s Why Bristol Myers Squibb Stock Is Undervalued At $63 Forbes09:01 29-Mar-21

International Myeloma Foundation Says FDA Approval of Bristol Myers Squibb's and bluebird bio's … PR Newswire (Press Release)08:52 29-Mar-21

Bristol Myers Squibb, bluebird land once-high-stakes approval on BCMA CAR-T — and it bodes well for rival J&J ENDPOINTS07:29 29-Mar-21

This Stalwart's Growth Story Isn't Over Yet The Motley Fool07:13 29-Mar-21

European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab)… Business Wire (Press Release)07:06 29-Mar-21

Bristol-Myers Squibb Company – Consensus Indicates Potential 20.1% Upside DirectorsTalk Interviews04:51 29-Mar-21

Bristol Myers Squibb's Floundering Days Could Be Behind It - Full Steam Ahead Seeking Alpha17:26 28-Mar-21

Bristol Myers Squibb, bluebird bio's multiple myeloma CAR-T ide-cel scores FDA nod FiercePharma07:52 28-Mar-21

U.S. FDA approves Bristol-Myers Squibb's multiple myeloma therapy Reuters01:29 27-Mar-21

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma… Business Wire (Press Release)23:03 26-Mar-21

Hunkering down on deals and racial diversity pledge amid pandemic, Giovanni Caforio took home $20M last year at Bristol … ENDPOINTS07:42 26-Mar-21

Bristol-Myers Squibb’s RELATIVITY-047 Trial Meets Primary Endpoint of Progression-Free Survival in Patients with… Trial Site News19:06 25-Mar-21

Bristol Myers Squibb CEO Caforio collected $20M in 2020 pay amid Celgene integration, pandemic… FiercePharma11:34 25-Mar-21

Thinking about trading options or stock in UnitedHealth Group, Funko, AstraZeneca, Johnson &… PR Newswire (Press Release)09:41 25-Mar-21

Bristol Myers Squibb outraces the pack to a late-stage trial win for its LAG-3/PD-1 antibody combo in melanoma ENDPOINTS09:40 25-Mar-21

Cadila Health settles patents case with US firm over anti-cancer drug Revlimid Livemint.com06:03 24-Mar-21

In a first, Merck's Keytruda snags FDA nod for esophageal cancer as stomach cancer label hangs… FiercePharma11:43 23-Mar-21

FDA Action Alert: Pacira, Zealand, bluebird and Bristol Myers Squibb BioSpace08:09 22-Mar-21

view more headlines

19 Apr 11:52

Bristol Myers Squibb News

NewsNow brings you the latest news from the world’s most trusted sources on Bristol Myers Squibb. NewsNow aims to be the world’s most accurate and comprehensive Bristol Myers Squibb news aggregator, bringing you the latest headlines automatically and continuously 24/7. N.B. Relevance is automatically assessed so some headlines not qualifying as Bristol Myers Squibb news might appear - please feel free to contact us regarding any persistent issues.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.